METHODS OF TREATING INFLAMMATORY SKIN DISORDERS

    公开(公告)号:US20230181693A1

    公开(公告)日:2023-06-15

    申请号:US17969971

    申请日:2022-10-20

    Applicant: NEPSONE EHF

    Inventor: Birkir SVEINSSON

    CPC classification number: A61K38/225 A61K9/0014 A61K38/23 A61P17/02 A61P17/06

    Abstract: A method for treating, remedying, or preventing inflammatory skin disorders by administering a therapeutically effective dose of at least one an antagonist of a calcitonin gene-related peptide receptor in a pharmaceutically acceptable formulation. The method for treating, remedying, or preventing an inflammatory skin disorder by administering topically and to the prepsoriatic rim a therapeutically effective dose of at least one an antagonist of a calcitonin gene-related peptide receptor in a pharmaceutically acceptable formulation.

    Orally bioavailable lipid-based constructs

    公开(公告)号:US10568835B2

    公开(公告)日:2020-02-25

    申请号:US14592205

    申请日:2015-01-08

    Applicant: SDG, INC.

    Abstract: The present invention is embodied by a composition capable of chaperoning a typically non-orally available therapeutic or diagnostic agent through the environment of the digestive tract such that the therapeutic or diagnostic agent is bioavailable. The composition may or may not be targeted to specific cellular receptors, such as hepatocytes. Therapeutic agents include, but are not limited to, insulin, calcitonin, serotonin, and other proteins. Targeting is accomplished with biotin or metal based targeting agents.

Patent Agency Ranking